Xerostomia Therapeutics Market Size

Xerostomia Therapeutics Market size was valued at USD 2.14 billion in 2024 and is set to exceed USD 3.52 billion by 2037, expanding at over 3.9% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of xerostomia therapeutics is evaluated at USD 2.21 billion.

The increase in adoption of radiation therapy and chemotherapy is likely to lead to an increased incidence of xerostomia, which is estimated to predominantly drive the xerostomia therapeutics market. Other factors driving the market growth include increasing usage of prescription medicines, easy availability and cost-effectiveness of medicines, growing geriatric population base and increasing prevalence of diseases, such as Sjogren’s syndrome, HIV, diabetes, and Alzheimer’s disease, among other diseases.  According to the Centres for Disease Control & Prevention (CDC), every year about 650,000 cancer patients receive chemotherapy in an outpatient oncology clinic.